Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights

Go back to Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
(NASDAQ: XERS) Delayed: 8.43 +0.44 (5.51%)
Previous Close $7.99    52 Week High
Open $8.00    52 Week Low
Day High $8.43    P/E N/A 
Day Low $7.96    EPS
Volume 966,836